Cognition Supplements Market Size and Share
Cognition Supplements Market Analysis by Mordor Intelligence
The Cognition Supplements Market size is estimated at USD 1.52 million in 2025, and is expected to reach USD 2.15 million by 2030, at a CAGR of 7.16% during the forecast period (2025-2030). Multiple factors contribute to this market expansion. Rising consumer awareness about cognitive health and mental well-being, driven by increased stress levels, digital fatigue, and demanding lifestyles, has prompted more people to purchase supplements for memory enhancement, focus, and brain function improvement. The growing aging population contributes significantly to market growth, as the prevalence of cognitive decline and neurodegenerative conditions increases with age, driving demand for brain health products. The wellness trend has encouraged regular use of these supplements within comprehensive health routines. Market growth is further supported by developments in personalized nutrition, diverse product formats including gummies and powders, and improved distribution through retail and e-commerce channels. The increasing prevalence of mental health conditions, such as anxiety and depression, has expanded the market as consumers seek multi-functional brain health supplements.
Key Report Takeaways
- By product type, natural molecules led with 46.11% cognition supplements market share in 2024, while vitamins and minerals recorded the highest projected CAGR at 8.69% through 2030.
- By form, capsules and tablets accounted for 52.65% of the cognition supplements market size in 2024; gummies and chewables are advancing at a 7.81% CAGR to 2030.
- By distribution channel, pharmacies held 47.23% revenue share of the cognition supplements market in 2024, whereas online retail is forecast to expand at 9.36% CAGR through 2030.
- By geography, North America captured 38.31% share of the cognition supplements market size in 2024, while Asia-Pacific is projected to grow at 6.44% CAGR between 2025 and 2030.
Global Cognition Supplements Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging population and cognitive decline awareness | +1.8% | Global, with highest impact in North America, Europe, and Asia-Pacific | Long term (≥ 4 years) |
| Preventive health and wellness trend | +1.2% | Global, particularly strong in developed markets | Medium term (2-4 years) |
| Growing consumer interest in natural and plant-based solutions | +1.0% | North America, Europe, with emerging adoption in Asia-Pacific | Medium term (2-4 years) |
| Growing prevalence of neurological disorders | +1.4% | Global, with higher impact in aging populations | Long term (≥ 4 years) |
| Integration with sports and E-sports nutrition | +0.8% | North America, Europe, Asia-Pacific urban centers | Short term (≤ 2 years) |
| Scientific research and product innovation | +0.9% | Global, led by North America and Europe | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Aging Population and Cognitive Decline Awareness
The aging population and increasing awareness of cognitive decline are driving the growth of the global cognition supplements market. As individuals age, the risk of cognitive impairments such as memory loss, Alzheimer's disease, and other neurodegenerative disorders increases, creating a need for preventive and supportive health measures. The focus on maintaining mental clarity, memory retention, and overall brain function has led consumers, particularly older adults, to adopt cognition supplements as part of their health regimen. This trend is supported by the effectiveness of natural molecules, vitamins, minerals, and herbal extracts in reducing cognitive decline and improving brain health. According to the Federal Interagency Forum on Child and Family Statistics, in 2024, approximately 18.3% of the American population was aged 65 years or older, an increase from 17.7% in the previous year [1]Source: Federal Interagency Forum on Child and Family Statistics, "Persons in selected age groups as a percentage of the total U.S. population", www.childstats.gov. This demographic shift increases the demand for products that support healthy aging, including cognition supplements for preserving and enhancing cognitive function.
Preventive-health and Wellness Trend
The growing emphasis on preventive health and wellness drives the global cognition supplements market as consumers prioritize proactive approaches to support brain health, memory, and focus before cognitive decline occurs. Rising awareness about lifestyle choices and stress affect cognitive performance has led individuals across age groups to incorporate supplements into their daily wellness routines, similar to the widespread adoption of multivitamins. This preventive approach is particularly strong among millennials and Gen Z, who embrace holistic health practices and use natural compounds to enhance mental clarity, productivity, and resilience. The integration of brain health into the broader wellness category, alongside fitness, sleep, and nutrition, reinforces this trend. For example, Reckitt's Neuriva launched the 30-Day Brain Health Challenge in February 2024, encouraging consumers to prioritize cognitive well-being daily. This initiative reflects the market's shift toward prevention and self-care while showing how companies engage consumers through structured wellness programs that promote behavioral change, increasing the demand for cognition supplements.
Growing Consumer Interest in Natural and Plant-Based Solutions
The increasing consumer inclination toward natural and plant-based solutions significantly influences the cognition supplements market dynamics. Consumers demonstrate a strong preference for wellness products that correspond to their fundamental values of health consciousness, environmental sustainability, and ethical consumption practices. Plant-based supplements derived from botanical sources, herbal compounds, and natural extracts maintain market prominence due to their established safety profile and reduced adverse effects in comparison to synthetic alternatives. Scientific research substantiates the efficacy of these natural ingredients in enhancing cognitive functions, including memory retention, attention span, and mental clarity, effectively integrating traditional herbal principles with contemporary nutraceutical advancements. In April 2025, Rasayanam introduced a premium plant-based Omega-3 supplement, specifically formulated to enhance cardiovascular health and cognitive performance. This product development initiative demonstrates the industry's strategic response to market demands for plant-based nutritional solutions, particularly addressing the requirements of vegan and vegetarian consumers, as well as individuals seeking products with transparent ingredient profiles.
Growing Prevalence of Neurological Disorders
The increasing prevalence of neurological disorders drives growth in the cognition supplements market. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and other neurodegenerative disorders impair cognitive function, creating demand for brain health supplements. According to the Italian National Institute of Statistics, approximately 2.72 million individuals in Italy suffered from neurological disorders by 2023, highlighting the significant burden of these conditions in developed countries with aging populations [2]Source: Italian National Institute of Statistics, "Number of individuals suffering from nervous disorders in Italy", www.istat.it. This trend has heightened awareness among the public and healthcare professionals about the importance of maintaining cognitive function. As a result, consumers, caregivers, and healthcare providers increasingly use cognition supplements to address cognitive decline, memory issues, and mental clarity. Additionally, the rising occurrence of neurological disorders has prompted research and development efforts, resulting in new supplement formulations that incorporate natural molecules, herbal extracts, and vitamins for neuroprotection and brain regeneration.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Adverse-effect and drug-interaction concerns | -1.1% | Global, with highest regulatory scrutiny in North America and Europe | Medium term (2-4 years) |
| Fragmented global regulatory frameworks | -0.9% | Global, particularly affecting cross-border market expansion | Long term (≥ 4 years) |
| High risk of misinformation and mislabeling | -0.7% | Global, with varying enforcement levels by region | Short term (≤ 2 years) |
| Short-term and long-rerm results debate | -0.5% | Primarily in developed markets with sophisticated consumers | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Adverse-effect and Drug-interaction Concerns
The cognition supplements market encounters substantial constraints due to documented adverse effects and pharmaceutical interactions. Specific botanical components, notably Ginkgo biloba, demonstrate increased hemorrhagic risk when administered concurrently with anticoagulant medications, while excessive consumption of vitamins B6 or niacin may result in toxicological manifestations. These medical considerations are particularly significant for geriatric populations, who frequently utilize multiple pharmaceutical interventions and constitute the primary market demographic. The heterogeneous nature of international dietary supplement regulations, encompassing disparate product safety protocols and labeling requirements across jurisdictions, introduces additional regulatory uncertainty. Heightened awareness regarding these safety implications may influence consumer preferences toward prescribed pharmaceutical interventions or complete supplement abstention, subsequently impeding market expansion.
Fragmented Global Regulatory Frameworks
The fragmented global regulatory frameworks restrict the cognition supplements market by creating complexity and barriers for manufacturers, distributors, and consumers. Different countries and regions maintain varying regulations for the formulation, labeling, claims, safety testing, ingredient approval, and marketing of cognition supplements. This regulatory inconsistency complicates product development and market entry strategies, requiring companies to navigate multiple compliance requirements across jurisdictions. While the Food and Drug Administration (FDA) 2024 updates expanded approvals for certain functional food ingredients, including nootropic compounds with specified usage levels and permitted health claims, regulatory variations between countries continue. The differences in ingredient approvals, labeling requirements, health claims substantiation, and safety standards increase operational costs and delay product launches across regions.
Segment Analysis
By Product Type: Natural Molecules Lead Innovation Pipeline
The Natural Molecules segment holds a dominant 46.11% share of the cognition supplements market in 2024. This leadership position results from increasing consumer preference for botanical compounds and scientific evidence supporting traditional herbal medicines. The segment's growth reflects heightened awareness of mental health and cognitive wellness across age groups. Consumers favor natural supplements for their perceived safety and holistic health benefits over synthetic alternatives. The segment's strong performance also builds on its foundation in traditional medicine systems, combining historical usage with modern scientific validation. Manufacturers continue to invest in clinical trials and product development to validate claims and enhance formulations. The rising prevalence of cognitive issues, along with changing lifestyle needs of millennials and aging populations, drives demand for natural cognitive enhancers.
Vitamins and minerals represent the fastest-growing segment in the cognition supplements market, with a projected CAGR of 8.69% through 2030. This growth stems from increased understanding of micronutrients' role in brain health and cognitive function. The segment encompasses essential components, including B-complex vitamins, vitamin D, and antioxidant compounds such as vitamin E, complemented by crucial minerals including magnesium, zinc, and iron. These elements have demonstrated efficacy in enhancing cognitive functions, particularly in areas of memory retention, sustained attention, and mental acuity. The market expansion is further supported by increasing consumer adoption of comprehensive dietary supplement formulations that incorporate balanced combinations of vitamins and minerals, addressing multiple aspects of cognitive enhancement through integrated nutritional solutions.
Note: Segment shares of all individual segments available upon report purchase
By Form: Gummies Disrupt Traditional Delivery
Capsules and tablets dominate the cognition supplements market, accounting for 52.65% share in 2024. Their market leadership is attributed to convenience, precise dosage control, stability, and broad consumer acceptance. These traditional formats enable consumers to integrate cognitive health supplements into their daily routines effectively. The formats also support advanced formulation technologies, including sustained and delayed release mechanisms, which enhance ingredient absorption and duration of effects. In July 2025, Ayush Wellness Limited introduced Brain Fuel Capsules, designed for cognitive function, memory retention, and mental clarity. The product incorporates herbal ingredients, reflecting consumer demand for natural, botanical-based supplements in capsule form. This launch reinforces the market's continued preference for capsules and tablets as primary delivery formats.
The gummies and chewable segment in the cognition supplements market is growing at a CAGR of 7.81%. This growth reflects consumer demand for palatable and convenient supplement formats that integrate easily into daily routines. These formats overcome traditional barriers of pills and capsules, such as swallowing difficulties and aftertaste issues, making them accessible to diverse age groups from children to older adults. Gummies promote higher adherence rates among users who typically struggle with regular supplement consumption. The segment's expansion is further evidenced by major brands and new market entrants increasing their gummy supplement offerings, indicating sustained growth potential in this category.
By Distribution Channel: Digital Commerce Transforms Access
Pharmacies and drug stores hold a 47.23% share of the cognition supplements market in 2024, establishing them as the primary distribution channel. This market leadership stems from consumer trust in pharmacies as reliable sources for health products and the availability of professional guidance. Pharmacies offer environments where consumers can receive personalized recommendations from healthcare professionals, particularly valuable for cognitive health supplements. The channel's strength comes from established supply chains, broad geographic presence, and extensive inventory of verified brands, which ensures product authenticity. The channel particularly serves older adults and health-conscious individuals who value safety and validated formulations.
Online retail has become the fastest-growing distribution channel for cognition supplements, with a CAGR of 9.36%. This growth reflects consumer preferences for convenient, accessible, and private purchasing options. E-commerce platforms allow consumers to research products extensively, compare prices, and access customer reviews before making purchases. The expansion of digital retail infrastructure and improvements in logistics and payment systems have strengthened online sales channels, enabling broader market reach. According to the Central Statistical Office of Poland, 19.8% of Polish consumers who regularly purchase medicine or dietary supplements used online channels in 2024 [3]Source: Central Statistical Office of Poland, "Share of people purchasing medicine and dietary supplements online in Poland", https://stat.gov.pl. This trend aligns with the global shift toward digital healthcare solutions, supported by increased internet access, mobile device usage, and consumer demand for convenient delivery options.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America holds the largest share of the global cognition supplements market at 38.31% in 2024. The region's advanced healthcare infrastructure enables comprehensive scientific research, clinical trials, and validation of cognitive health products. The market growth is driven by high consumer awareness of brain health, increasing cognitive disorders, and an aging population. North American consumers demonstrate a strong willingness to invest in cognitive health solutions, supported by their health consciousness and product knowledge. The regulatory frameworks in the United States and Canada allow manufacturers to validate clinical claims effectively, enhancing consumer confidence. The market benefits from extensive distribution networks across pharmacies, specialty stores, and e-commerce platforms.
Asia-Pacific exhibits the highest growth rate at 6.44% CAGR through 2030. This growth stems from demographic changes, increasing urbanization, and the integration of traditional medicine with modern nutrition science. Market expansion in China, Japan, and India is driven by aging populations seeking cognitive health solutions and increased disposable income levels. The regional market benefits from widespread acceptance of herbal medicines and preventive healthcare practices. However, diverse regulatory requirements across countries necessitate strategic local partnerships and adapted market entry approaches.
Europe maintains a developed market position with high-quality standards and evidence-based product validation. The region's regulatory framework requires scientific proof for health claims, creating market entry challenges while ensuring product credibility. European consumers prioritize organic and sustainably sourced ingredients with documented supply chains, driving advancements in extraction methods and quality control. South America and the Middle East and Africa present growth opportunities, though success requires substantial investment in regulatory compliance and consumer education programs.
Competitive Landscape
The cognition supplements market shows moderate fragmentation, comprising established pharmaceutical companies and emerging players. Large pharmaceutical firms use acquisitions to expand their portfolios and gain nootropics expertise, while smaller companies focus on clinical validation and direct-to-consumer models to strengthen customer relationships. Key market players include Amway Corp., NOW Foods, Herbalife Nutrition Ltd., Bayer AG, and Reckitt Benckiser Group PLC. These companies utilize their brand strength and distribution networks while investing in research, product development, and marketing to meet increasing consumer demand for cognitive wellness products.
Companies are implementing technology solutions to differentiate themselves in the market. This includes developing personalized nutrition algorithms that analyze individual cognitive requirements and lifestyle factors to provide supplement recommendations. Companies now offer at-home testing platforms for cognitive health monitoring and subscription-based delivery services. These technological implementations help companies generate recurring revenue, maintain customer loyalty, and provide consistent product access while offering personalized engagement.
The market offers expansion opportunities through personalized formulations based on genetic testing, biomarker analysis, and lifestyle assessments. Companies are developing algorithms that combine clinical data and genetic information to create individual supplement recommendations. This approach addresses consumer demand for products customized to specific health profiles. Companies that effectively utilize data analytics and personalization technologies position themselves to gain market share and attract new consumer segments, contributing to market growth and innovation.
Cognition Supplements Industry Leaders
-
Amway Corp.
-
NOW Foods
-
Herbalife Nutrition Ltd.
-
Bayer AG
-
Reckitt Benckiser Group PLC
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- September 2025: Reckitt Benckiser Group's brand Neuriva introduced Memory 3D Formula, which contains two clinically tested ingredients - Cognicell and Neurofactor - to support memory function.
- July 2025: MemoCore Drops, a cognitive support supplement, launched to support brain health, memory retention, and mental clarity. The supplement contains Bacopa Monnieri, Ginkgo Biloba, Phosphatidylserine, and Vitamin B Complex.
- November 2024: Bayer launched Berocca Mind, which contains Spanish Sage to support memory function. The effervescent tablets contain 12 essential vitamins and minerals, including all eight B vitamins, magnesium to reduce tiredness and fatigue, and zinc and iron to support normal cognitive function.
- March 2024: BioTRUST Nutrition introduced Eternal Mind, a cognitive support supplement. The product contains PLT's Nutricog Cognitive Performance Complex, which clinical studies show improves multiple aspects of cognitive function.
Global Cognition Supplements Market Report Scope
Cognition supplements are dietary supplements designed to boost cognitive functions, including memory, focus, attention, and mental clarity. The Global Cognition Supplements Market is segmented by product type, form, distribution channel, and geography. By product type, the market is segmented into natural molecules, herbal extracts, and vitamins & minerals. By form, the market is bifurcated into chewable and capsules. By distribution channel, the market is segmented into supermarkets/hypermarkets, pharmacies/drug stores, online retail channels, and other distribution channels. Also, the study analyzes the dietary supplements market in emerging and established markets worldwide, including North America (United States, Canada, Mexico, and the Rest of North America), Europe (United Kingdom, Germany, France, Russia, Italy, Spain and Rest of Europe), Asia-Pacific( China, Japan, India, Australia and Rest of Asia-Pacific), South America ( Brazil, Argentina and Rest of South America), Middle-East and Africa (South Africa and Saudi Arabia and Rest of Middle-East and Africa). The market sizing has been done in value terms in USD for all the abovementioned segments.
| Natural Molecules |
| Herbal Extracts |
| Vitamins and Minerals |
| Others |
| Capsules and Tablets |
| Powders |
| Gummies and Chewables |
| Supermarkets/Hypermarkets |
| Pharmacies/Drug Stores |
| Online Retail Stores |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Rest of North America | |
| Europe | United Kingdom |
| Germany | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | India |
| China | |
| Japan | |
| Australia | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Middle East and Africa | South Africa |
| Saudi Arabia | |
| Rest of Middle East and Africa |
| By Product Type | Natural Molecules | |
| Herbal Extracts | ||
| Vitamins and Minerals | ||
| Others | ||
| By Form | Capsules and Tablets | |
| Powders | ||
| Gummies and Chewables | ||
| By Distribution Channel | Supermarkets/Hypermarkets | |
| Pharmacies/Drug Stores | ||
| Online Retail Stores | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Rest of North America | ||
| Europe | United Kingdom | |
| Germany | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | India | |
| China | ||
| Japan | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Middle East and Africa | South Africa | |
| Saudi Arabia | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What is the current value of the cognition supplements market?
The cognition supplements market size stands at USD 1.52 billion in 2025 and is on track to reach USD 2.15 billion by 2030.
Which product category dominates brain-health supplements?
Natural molecules hold 46.11% cognition supplements market share thanks to strong consumer preference for plant-based actives.
Which sales channel is expanding fastest?
Online retail is forecast to grow at 9.36% CAGR as personalized e-commerce platforms gain traction.
Which region offers the highest growth potential?
Asia-Pacific is projected to post a 6.44% CAGR through 2030, fueled by urbanization, income gains, and aging demographics.
Page last updated on: